全文获取类型
收费全文 | 247篇 |
免费 | 14篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 13篇 |
妇产科学 | 7篇 |
基础医学 | 21篇 |
口腔科学 | 8篇 |
临床医学 | 13篇 |
内科学 | 59篇 |
神经病学 | 6篇 |
特种医学 | 3篇 |
外科学 | 39篇 |
综合类 | 2篇 |
预防医学 | 46篇 |
眼科学 | 3篇 |
药学 | 21篇 |
肿瘤学 | 19篇 |
出版年
2023年 | 3篇 |
2022年 | 7篇 |
2021年 | 22篇 |
2020年 | 14篇 |
2019年 | 13篇 |
2018年 | 11篇 |
2017年 | 11篇 |
2016年 | 5篇 |
2015年 | 8篇 |
2014年 | 11篇 |
2013年 | 22篇 |
2012年 | 20篇 |
2011年 | 19篇 |
2010年 | 9篇 |
2009年 | 7篇 |
2008年 | 16篇 |
2007年 | 16篇 |
2006年 | 13篇 |
2005年 | 6篇 |
2004年 | 5篇 |
2003年 | 3篇 |
2002年 | 4篇 |
2001年 | 7篇 |
2000年 | 1篇 |
1999年 | 3篇 |
1998年 | 1篇 |
1994年 | 1篇 |
1990年 | 1篇 |
1983年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有261条查询结果,搜索用时 15 毫秒
1.
Olafsson S Berstad A Bang CJ Nysaeter G Coll P Tefera S Hatlebakk JG Hausken T Olafsson T 《Alimentary pharmacology & therapeutics》1999,13(5):651-659
BACKGROUND: We have consistently achieved about 90% eradication of H. pylori with liquid bismuth, metronidazole and oxytetracycline. AIM: To test eradication and adverse events of ranitidine bismuth citrate (RBC) when given with metronidazole and either oxytetracycline or spiramycin. METHODS: One hundred and eighty-three patients were randomized to one of four 10-day regimens: RBC400OM: RBC 400 mg b.d., oxytetracycline 500 mg q.d.s.; RBC400SM: RBC 400 mg b.d., spiramycin 1 g q.d.s.; RBC200OM: RBC 200 mg q.d.s., oxytetracycline 500 mg q.d.s.; RBC200SM: RBC 200 mg q.d.s., spiramycin 1 g q.d.s. Additionally, all patients received metronidazole 400 mg q.d.s. A 14C-urea breath test was performed at 8 weeks. RESULTS: Intention-to-treat eradication rates were 94%, 91%, 94% and 89% with RBC400OM, RBC400SM, RBC200OM and RBC200SM, respectively (P = 0.81). Eradication was significantly higher in ulcer patients (97%) than in those with diagnoses other than ulcer (86%) (P = 0.009). There was a strong tendency to better eradication among those who had never smoked (100%) compared with ex-smokers (93%) and smokers (89%) (P = 0.06). Fifty-three per cent experienced at least one moderate or severe adverse event, and women had more adverse events than men (P = 0.0002). CONCLUSIONS: All four regimens had comparable efficacy and adverse events. Eradication was significantly better in ulcer patients but there was a trend to better eradication in those who smoked less, used less alcohol and exercised more. Adverse events were frequent, perhaps because of the large dose of metronidazole used, but few patients stopped treatment. 相似文献
2.
Clamp and sew techniques in thoracoabdominal aortic surgery using naloxone and CSF drainage 总被引:1,自引:0,他引:1
Surgical repair of thoracoabdominal (TAA) and thoracic aneurysm is challenging, with the potentials for high morbidity and mortality. There is no standardized operative approach. Operative management of TAA consists of simple clamp-and-sew techniques with adjuncts, cerebrospinal fluid (CSF) drainage, naloxone administration, and intraoperative hypothermia, to protect the spinal cord. The use of CSF drainage and naloxone administration has reduced paraplegia to 3.4%, compared with 21% when none of these adjunctive spinal cord measures were used. The authors discuss their operative strategy, surgical technique, and results at the University of Wisconsin Hospital and Clinics. 相似文献
3.
Eshetu Sata Andrew W. Nute Tigist Astale Demelash Gessese Zebene Ayele Mulat Zerihun Ambahun Chernet Berhanu Melak Kimberly A. Jensen Mahteme Haile Taye Zeru Melkamu Beyen Adisu Abebe Dawed Fikre Seife Zerihun Tadesse Elizabeth Kelly Callahan Jeremiah Ngondi Scott D Nash 《The American journal of tropical medicine and hygiene》2021,104(4):1278
4.
5.
6.
7.
Waters V Stanojevic S Atenafu EG Lu A Yau Y Tullis E Ratjen F 《The European respiratory journal》2012,40(1):61-66
It is unknown what proportion of long-term lung function decline in cystic fibrosis (CF) is explained by pulmonary exacerbations. The aim of this study was to determine how exacerbations requiring hospitalisation contribute to the course of CF lung disease. This was a retrospective cohort study. The primary outcome was the rate of decline of forced expiratory volume in 1 s (FEV(1)) % predicted. Out of 851 subjects, 415 (48.8%) subjects had ≥ 1 exacerbation. After adjustment for confounders, the annual rate of FEV(1) decline in those without an exacerbation was 1.2% per yr (95% CI 1.0-1.5), compared with 2.5% per yr (95% CI 2.1-2.8) in those with an exacerbation. The proportion of overall FEV(1) decline associated with ≥ 1 exacerbation was 52% (95% CI 35.0-68.9). For a given number of exacerbations, the annual rate of FEV(1) decline was greatest in subjects with ≤ 6 months between exacerbations. Half of FEV(1) decline seen in CF patients was associated with pulmonary exacerbations. Time between exacerbations, specifically ≤ 6 months between exacerbations, plays an important contribution to overall lung function decline. These findings support using time to next exacerbation as a clinical end-point for CF trials. 相似文献
8.
Valerie Waters Eshetu G. Atenafu Annie Lu Yvonne Yau Elizabeth Tullis Felix Ratjen 《Journal of cystic fibrosis》2013,12(5):482-486
BackgroundChronic Stenotrophomonas maltophilia infection is an independent risk factor for severe pulmonary exacerbations in cystic fibrosis (CF) patients. The goal of this study was to determine the effect of chronic S. maltophilia infection on mortality and the need for lung transplantation in a longitudinal study of children and adults with CF.MethodsThis was a cohort study of CF patients from the Hospital for Sick Children and St Michael's Hospital (Toronto, Canada) from 1997 to 2008. A Cox Regression model was used to estimate the hazard ratio (HR) to time of death or lung transplantation adjusting for age, gender, genotype, pancreatic status, CF related diabetes (CFRD), forced expiratory volume in 1 s (FEV1), body mass index, number of pulmonary exacerbations, Pseudomonas aeruginosa, Burkholderia cepacia complex, Aspergillus and chronic S. maltophilia infection.ResultsA total of 687 patients were followed over the 12 year study period; 95 patients underwent a lung transplantation (of which 26 died) and an additional 49 patients died (total 144 events). In a Cox Regression model adjusting for baseline FEV1, baseline infection with B. cepacia complex (HR 1.72, 95% CI 1.09–2.71) and baseline chronic S. maltophilia infection (HR 2.80, 95% CI 1.65–4.76) were significantly associated with death or lung transplant. However, in a time-varying model, infection with B. cepacia complex and chronic S. maltophilia infection were no longer significant.ConclusionsBaseline chronic S. maltophilia infection is associated with an almost three-fold increased risk of death or lung transplant in CF patients. It is still unclear, however, whether chronic S. maltophilia infection is simply a marker of severity of disease and ultimate mortality or whether it is causally related to disease progression. 相似文献
9.
Meredith L. Johnston MBBS Shao Hui Huang MSc John N. Waldron MD Eshetu G. Atenafu MSc Kelvin Chan MD MSc Bernard J. Cummings MBChB Ralph W. Gilbert MD David Goldstein MD Patrick J. Gullane MB Jonathan C. Irish MD MSc Bayardo Perez–Ordonez MD Ilan Weinreb MD Andrew Bayley MD John Cho MD PhD Laura A. Dawson MD Andrew Hope MD Jolie Ringash MD MSc Ian J. Witterick MD Brian O'Sullivan MD John Kim MD 《Head & neck》2016,38(Z1):E820-E826
10.